ES2173087T3 - Compuesto de azetidinona y procedimiento para su preparacion. - Google Patents

Compuesto de azetidinona y procedimiento para su preparacion.

Info

Publication number
ES2173087T3
ES2173087T3 ES93118085T ES93118085T ES2173087T3 ES 2173087 T3 ES2173087 T3 ES 2173087T3 ES 93118085 T ES93118085 T ES 93118085T ES 93118085 T ES93118085 T ES 93118085T ES 2173087 T3 ES2173087 T3 ES 2173087T3
Authority
ES
Spain
Prior art keywords
substituent
procedure
preparation
azetidinone compound
oxygen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118085T
Other languages
English (en)
Inventor
Tameo Iwasaki
Kazuhiko Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2173087T3 publication Critical patent/ES2173087T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE PRESENTA UN COMPUESTO DE AZETIDINONA DE LA FORMULA [I]: EN DONDE EL ANILLO B ES UN ANILLO DE BENCENO QUE PUEDE TENER UNO O MAS SUSTITUYENTES, R'' ES UN GRUPO ALKILO INFERIOR SUSTITUIDO POR HIDROXI Y QUE PUEDE TENER UNO O MAS SUSTITUYENTES, X ES UN ATOMO DE OXIGENO Y SIMILAR, Y ES UN ATOMO DE OXIGENO Y SIMILAR Y Z ES UN GRUPO METILENO QUE PUEDE TENER UNO O MAS SUSTITUYENTES Y CUYO COMPUESTO ES UTIL COMO INTERMEDIO SINTETICO DEL AGENTE ANTIBACTERIANO DEL TIPO 1(BETA)METILCARBAPENEM.
ES93118085T 1992-11-13 1993-11-08 Compuesto de azetidinona y procedimiento para su preparacion. Expired - Lifetime ES2173087T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP30366292 1992-11-13
JP11146093 1993-05-13
JP16918293 1993-07-08
JP23815593 1993-09-24

Publications (1)

Publication Number Publication Date
ES2173087T3 true ES2173087T3 (es) 2002-10-16

Family

ID=27469913

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118085T Expired - Lifetime ES2173087T3 (es) 1992-11-13 1993-11-08 Compuesto de azetidinona y procedimiento para su preparacion.

Country Status (12)

Country Link
US (1) US5442055A (es)
EP (1) EP0597423B1 (es)
JP (1) JP2897153B2 (es)
KR (3) KR100231223B1 (es)
AT (1) ATE214061T1 (es)
CA (1) CA2102772C (es)
DE (1) DE69331652T2 (es)
DK (1) DK0597423T3 (es)
ES (1) ES2173087T3 (es)
IL (2) IL107532A (es)
PT (1) PT597423E (es)
SG (1) SG50416A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731431A (en) * 1991-12-26 1998-03-24 Nippon Soda Co., Ltd. Process for preparing 4-substituted azetidinone derivatives
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
EP0632037B1 (en) * 1993-06-30 1997-10-01 Tanabe Seiyaku Co., Ltd. Process for the production of 4-substituted azetidinone derivatives
JPH09143156A (ja) * 1995-11-17 1997-06-03 Tanabe Seiyaku Co Ltd アセトキシアゼチジノン誘導体の製法及びその合成中間体
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 ４−置換アゼチジノン誘導体の製造方法
KR100377448B1 (ko) * 2000-08-10 2003-03-26 동화약품공업주식회사 카바페넴 항생물질의 중간체 및 그의 제조방법
JP2008056564A (ja) * 2004-11-12 2008-03-13 Shionogi & Co Ltd アゼチジノン誘導体の製造方法
PT2326648E (pt) 2008-07-30 2012-10-31 Ranbaxy Lab Ltd Processo de preparação de compostos de carbapenem
PL2464645T3 (pl) 2009-07-27 2017-12-29 Gilead Sciences, Inc. Skondensowane heterocykliczne związki jako modulatory kanałów jonowych
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
MX361350B (es) 2011-05-10 2018-12-04 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal de sodio.
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (es) 2011-07-01 2018-04-28
CN108774188A (zh) * 2018-07-23 2018-11-09 湖北宇阳药业有限公司 一种美罗培南中间体的制备方法
CN110025619B (zh) * 2019-04-29 2022-03-22 江苏汉阔生物有限公司 美罗培南中间体在制备抗氧化药物中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
EP0010348A1 (en) * 1978-09-12 1980-04-30 Imperial Chemical Industries Plc Heterocyclic trichloromethyl derivatives, process for their preparation and their use
US4350631A (en) * 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
JPS5910570A (ja) * 1982-07-08 1984-01-20 Wakamoto Pharmaceut Co Ltd 新規イソカルボスチリル誘導体及びその製法
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS615081A (ja) * 1984-06-18 1986-01-10 Sankyo Co Ltd １−置換カルバペネム−３−カルボン酸誘導体の製造法
DK270685A (da) * 1984-06-29 1985-12-30 Hoffmann La Roche Carbapenemderivater
JPS6225286A (ja) * 1985-07-26 1987-02-03 株式会社東芝 核融合装置用電源装置
JPS6277384A (ja) * 1985-10-01 1987-04-09 Nippon Redarii Kk アゼチジン−２−オン誘導体及びその製造方法
CA1282415C (en) * 1985-08-31 1991-04-02 Yasuhiro Kuramoto Azetidin-2-on derivatives and process for production thereof
JPS62252785A (ja) * 1986-01-08 1987-11-04 Sankyo Co Ltd ４−置換β−ラクタム化合物
JPS62169781A (ja) * 1986-01-21 1987-07-25 Sankyo Co Ltd β−ラクタム化合物
JP2789190B2 (ja) * 1986-01-27 1998-08-20 住友製薬株式会社 新規なβ−ラクタム誘導体およびその製造法
GB8607921D0 (en) * 1986-04-01 1986-05-08 Fujisawa Pharmaceutical Co 3,4-disubstituted-2-azetidinone derivatives
JP2510860B2 (ja) * 1987-02-02 1996-06-26 住友製薬株式会社 新規なβ−ラクタム誘導体の製造方法
JPS63284176A (ja) * 1987-05-15 1988-11-21 Nippon Redarii Kk （１ｒ，５ｒ，６ｓ）−６−〔（１ｒ）−１−ヒドロキシエチル〕−１−メチルカルバペネム−３−カルボン酸誘導体の高立体選択的製造方法
ES2067534T3 (es) * 1988-04-01 1995-04-01 Sankyo Co Derivados de 2-(heterocicliltio)carbapenemo, su preparacion y su aplicacion como antibioticos.
JPH02178262A (ja) * 1988-12-28 1990-07-11 Sumitomo Pharmaceut Co Ltd １―（２′―ハロプロピオニル）ピロリジン―２―オン誘導体
JPH0662547B2 (ja) * 1989-01-10 1994-08-17 田辺製薬株式会社 グリシン誘導体
JPH02292269A (ja) * 1989-05-06 1990-12-03 Lederle Japan Ltd 活性アミド化合物
CA2050255C (en) * 1990-09-07 1997-02-04 Tameo Iwasaki 1-methylcarbapenem derivatives and process for preparation thereof
JP3220985B2 (ja) * 1991-12-26 2001-10-22 日本曹達株式会社 ４−置換アゼチジノン誘導体の製造方法

Also Published As

Publication number Publication date
JPH07165760A (ja) 1995-06-27
EP0597423A3 (en) 1995-04-12
IL121842A0 (en) 1998-02-22
JP2897153B2 (ja) 1999-05-31
CA2102772A1 (en) 1994-05-14
DK0597423T3 (da) 2002-05-21
EP0597423B1 (en) 2002-03-06
IL107532A0 (en) 1994-02-27
US5442055A (en) 1995-08-15
EP0597423A2 (en) 1994-05-18
KR100252404B1 (en) 2000-04-15
CA2102772C (en) 2001-04-03
KR940011460A (ko) 1994-06-21
PT597423E (pt) 2002-06-28
IL107532A (en) 1999-06-20
ATE214061T1 (de) 2002-03-15
KR100231223B1 (ko) 1999-11-15
DE69331652D1 (de) 2002-04-11
KR100256863B1 (ko) 2000-05-15
DE69331652T2 (de) 2002-10-17
SG50416A1 (en) 1998-07-20

Similar Documents

Publication Publication Date Title
ES2173087T3 (es) Compuesto de azetidinona y procedimiento para su preparacion.
ATE124699T1 (de) Tricyclische carbapenemverbindungen.
PT705833E (pt) Derivado de dc-89
AU1282495A (en) Anthranilic acid derivative
PT918776E (pt) Sintese total de acilfulvenos antitumorais
EP0632031A4 (es)
AU648338B2 (en) Benzene, pyridine and pyrimidine derivatives
AU2623192A (en) Antifungal agent
PE34996A1 (es) Nuevo derivado de pirrocarbazol
IL118367A0 (en) Heteroaroyl derivatives
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
ES2087247T3 (es) Inhibidor de aldosa reductasa.
ES2146661T3 (es) Nuevos derivados de cefem.
AU4983790A (en) Aralkylamine compounds
EP0987255A3 (en) Substituted aminoquinazolinone (thione) derivatives
AU623500B2 (en) Carboxylimino benzothiazole derivatives
GB9015485D0 (en) Heterocyclic derivatives
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 597423

Country of ref document: ES